1. 3338 Initial safety results from a multinational, prospective, observational study in advanced melanoma (MEL) (IMAGE). (September 2015) Authors: Middleton, M.; Dalle, S.; Corrie, P.; Loquai, C.; Terheyden, P.; Kähler, K.C.; Meiss, F.; Board, R.; Arance, A.M.; Gutzmer, R.; Tarhini, A.; Dummer, R.; Ernst, S.; Richtig, E.; Wolter, P.; Bulger, K.; Kotapati, S.; Le, T.K.; Brokaw, J.; Abernethy, A.P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S678 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A new clinical variant of acquired reactive perforating dermatosis‐like bullous pemphigoid. (13th November 2018) Authors: Schauer, F.; Kern, J.S.; Virtic, O.; Technau‐Hafsi, K.; Meiss, F.; Thoma, K.; Athanasiou, I.; Sitaru, C.; Di Zenzo, G.; Izumi, K.; Nishie, W.; Shimizu, H.; Bruckner‐Tuderman, L.; Kiritsi, D. Journal: British journal of dermatology Issue: Volume 180:Number 1(2019) Page Start: 231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A new clinical variant of acquired reactive perforating dermatosis‐like bullous pemphigoid. (1st January 2019) Authors: Schauer, F.; Kern, J.S.; Virtic, O.; Technau‐Hafsi, K.; Meiss, F.; Thoma, K.; Athanasiou, I.; Sitaru, C.; Di Zenzo, G.; Izumi, K.; Nishie, W.; Shimizu, H.; Bruckner‐Tuderman, L.; Kiritsi, D. Journal: British journal of dermatology Issue: Volume 180:Number 1(2019) Page Start: 231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Alitretinoin in the treatment of palmoplantar mycosis fungoides: a new and promising therapeutic approach. (1st June 2015) Authors: Miernik, B.; Schmidt, V.; Technau‐Hafsi, K.; Kern, J. S.; Meiss, F. Journal: Clinical and experimental dermatology Issue: Volume 40:Number 4(2015) Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Alitretinoin in the treatment of palmoplantar mycosis fungoides: a new and promising therapeutic approach. (5th December 2014) Authors: Miernik, B.; Schmidt, V.; Technau‐Hafsi, K.; Kern, J. S.; Meiss, F. Journal: Clinical and experimental dermatology Issue: Volume 40:Number 4(2015) Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study. (10th March 2020) Authors: Brüggen, M.‐C.; Valencak, J.; Stranzenbach, R.; Li, N.; Stadler, R.; Jonak, C.; Bauer, W.; Porkert, S.; Blaschke, A.; Meiss, F.; Nicolay, J. P.; Wehkamp, U.; Schlaak, M.; Nguyen, V.A.; Romani, N.; Cozzio, A.; Gayathri, N.; Dimitriou, F.; French, L. E.; Dummer, R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 7(2020) Page Start: 1489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Combined anti‐inflammatory and low‐dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. (2nd September 2019) Authors: Reimer, A.; Lu, S.; He, Y.; Bruckner‐Tuderman, L.; Technau‐Hafsi, K.; Meiss, F.; Has, C.; von Bubnoff, D. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 1(2020) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Esophageal carcinoma in severe recessive dystrophic epidermolysis bullosa—an underestimated complication?. (2nd December 2021) Authors: Schwieger‐Briel, A.; Trefzer, L.; Schumann, H.; Reimer‐Taschenbrecker, A.; Rafei‐Shamsabadi, D.; Meiss, F.; Has, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 4(2022) Page Start: e293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PO-1814: RT-induced abscopal effect despite unfavorable pretreatment immune signature. (November 2020) Authors: Firat, E.; Watanabe, T.; Scholber, J.; Luo, R.; Ehrat, N.; Meiss, F.; Niedermann, G. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S1011 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prospective evaluation of follow-up in melanoma patients in Germany – Results of a multicentre and longitudinal study. Issue 5 (March 2015) Authors: Livingstone, E.; Krajewski, C.; Eigentler, T.K.; Windemuth-Kieselbach, C.; Benson, S.; Elsenbruch, S.; Hauschild, A.; Rompel, R.; Meiss, F.; Mauerer, A.; Kähler, K.C.; Dippel, E.; Möllenhoff, K.; Kilian, K.; Mohr, P.; Utikal, J.; Schadendorf, D. Journal: European journal of cancer Issue: Volume 51:Issue 5(2015:Mar.) Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗